These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3477674)

  • 1. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia].
    Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D
    Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674
    [No Abstract]   [Full Text] [Related]  

  • 2. [HTLV-III infection in risk groups].
    Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J
    Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area].
    Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M
    Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibodies against the LAV/HTLV-III retroviruses etiologically associated with AIDS in the Yugoslav population at increased risk].
    Cobić P; Vujić A; Litvinjenko S; Imami O; Vucković V
    Srp Arh Celok Lek; 1986 Apr; 114(4):383-91. PubMed ID: 3506789
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human T-lymphotropic virus (HTLV-III) antibodies in intravenous drug addicts from the Valencia community].
    Rodrigo JM; Serra MA; Aguilar E; Ample I; Gimeno V; del Olmo JA; Escudero A; Aparisi L; Wassel A; Sanmartín B
    Med Clin (Barc); 1986 Jan; 86(3):89-92. PubMed ID: 3007886
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infection with the hepatitis B virus (HBV), the human T-lymphotropic retrovirus (HIV) and Treponema pallidum in jailed minors].
    Migneco G; Valentino L; Navetta A; Lampiasi AM; Bagnasco D; Lupo G
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):241-5. PubMed ID: 3307838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of neopterin, gamma interferon and other immunologic parameters determined in a population of drug addicts, positive or negative for anti-HTLV III antibodies].
    Soffritti E; Dallara G; Bernardoni R; Ferrari R; Pelizzola D; Cicognani I; Gallerani M; Colamussi V; Cazzuffi S; Scaglianti G
    G Clin Med; 1987 Feb; 68(2):87-95. PubMed ID: 3111926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sequential examination of anti-human immunodeficiency virus (HIV) antibodies by Western blot analysis and immunity in hemophiliacs].
    Toyoda Y; Tonouchi T; Mimaya J; Takahashi S; Sugiyama T
    Rinsho Ketsueki; 1988 Apr; 29(4):513-9. PubMed ID: 3043040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression in homosexual men seronegative for HTLV-III.
    Ranki A; Valle SL; Antonen J; Suni J; Jokipii L; Jokipii AM; Saxinger C; Krohn K
    Cancer Res; 1985 Sep; 45(9 Suppl):4616s-4618s. PubMed ID: 3160458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AIDS: an assessment of the potential occupational risk in the dental environment for HIV (human immunodeficiency virus) infection].
    Avoni A; Borea G; Chiodo F; Costigliola P; Ricchi E
    Minerva Stomatol; 1986 Oct; 35(10):941-6. PubMed ID: 3467166
    [No Abstract]   [Full Text] [Related]  

  • 17. Seropositivity to LAV/HTLV-III in 11 European countries.
    Ebbesen P; Melbye M; Jeffries J; Antonen J; Valle SL; Suni J; Ranki A; Krohn K; Chermann JC; Koch MA
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1453-6. PubMed ID: 3474150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HTLV-III, virus hepatitis B and CMV in Chilean homosexuals].
    Velasco M; Sepúlveda C
    Rev Med Chil; 1985 Jun; 113(6):587-9. PubMed ID: 3010422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological and cytochemical changes in groups at risk for acquired immunodeficiency syndrome and in symptomatic and asymptomatic carriers of antibodies to human immunodeficiency virus. A multivariate study].
    Gutiérrez Martín M; Romero Colás MS; Callén Sevilla L; Lasierra Díaz P; Larrad Mur L
    Med Clin (Barc); 1987 Oct; 89(13):544-8. PubMed ID: 3320599
    [No Abstract]   [Full Text] [Related]  

  • 20. [Penetration of anti-LVA/HTLV-III in type A and B hemophiliacs. Clinical and immunologic follow-up].
    Ollero M; Leal M; Ramsey R; Wichman I; Vinuesa M; Muñoz J; Palmer E; Lissen E
    Med Clin (Barc); 1986 Jan; 86(3):100-4. PubMed ID: 3485746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.